Projects per year
Personal profile
Biography
I have an extensive background in experimental studies and physico-chemical characterization of surfaces, interfaces, nanoscale layers and particle materials in close connection to material science, biophysics and nanotechnology. I received my PhD in 1999 from the Department of Physical Chemistry at Åbo Akademi University. After this I worked 10 years at KSV Instruments Ltd/Biolin Scientific Oy, a company providing high-tech, precision analytical instruments for nanoscale study of interfaces. In January 2010 I returned to academia as a senior researcher at University of Helsinki and held an Academy of Finland Research Fellow position between August 2010 - July 2015. In 2018 I obtained a university lecturer position in pharmaceutical technology at University of Helsinki, and since 1.9.2021 I have been appointed as a professor in New Drug Formulations (position shared between University of Helsinki and Åbo Akademi University). I am also a group leader of the Pharmaceutical Biophysics research group at the Faculty of Pharmacy at University of Helsinki and a member of the BioNanoMaterials group at Åbo Akademi University. My main research focus is to utilize model surfaces, living cells, nanoscience and –technology, and various physico-chemical label-free characterization techniques (e.g., surface plasmon resonance, quartz crystal microbalance and time-resolved Raman spectroscopy) and well-established tools in life sciences to improve the mechanistic understanding of drug and nanoparticle action and delivery.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
External positions
Professor, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki
1 Sept 2021 → …
Docent in Pharmaceutical Nanotechnology, Faculty of Pharmacy, University of Helsinki
1 Sept 2020 → …
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 5 Active
-
MADNESS: Centre of Excellence in Materials-driven solutions for combatting antimicrobial resistance
Rosenholm, J. (Principal Investigator), Porres Paltor, I. (Co-Principal Investigator), Bansal, K. (Coordinator), Lafond, S. (Co-Principal Investigator), Uppstu, P. (Co-Principal Investigator), Viitala, T. (Co-Principal Investigator), Wang, X. (Co-Principal Investigator), Wilen, C.-E. (Co-Principal Investigator), Xu, C. (Co-Principal Investigator), Zhang, H. (Co-Principal Investigator), Lu, Z. (Co-Investigator), Verma, J. (Co-Investigator), Kumar, V. (Co-Investigator), Frejborg, F. (Co-Investigator), Wang, S. (Co-Investigator), Ran, M. (Co-Investigator), Ma, X. (Co-Investigator), Yang, W. (Co-Investigator), Liang, S. (Co-Investigator), Zhang, Y. (Co-Investigator), Fan, L. (Co-Investigator), Chen, Y. (Co-Investigator), Wang, L. (Co-Investigator), Zhuang, P. (Co-Investigator), Peltomäki, J. (Co-Investigator), Rajan Prakash, D. (Co-Investigator), Howaili, F. (Co-Investigator), Gulshan, R. (Co-Investigator), Yadav, D. (Co-Investigator), Pathak, C. (Co-Investigator), Mustafa, R. (Co-Investigator) & Rostami, L. (Co-Investigator)
01/01/24 → 31/12/28
Project: Foundation
-
Nordic Pharmaceutical Translation and Innovation
Rosenholm, J. (Principal Investigator), Viitala, T. (Co-Principal Investigator), Zhang, H. (Co-Principal Investigator), Salo-Ahen, O. (Co-Principal Investigator), Filppula, A. (Co-Principal Investigator), Wang, X. (Co-Principal Investigator), Bansal, K. (Co-Investigator), Kulkov, I. (Co-Investigator), Ameyaw Ahen, F. (Co-Investigator), Salminen, T. A. (Co-Principal Investigator), Airenne, T. (Co-Investigator), Lehtonen, J. (Co-Investigator), Södergård, B. (Co-Investigator) & Rosenberg, S. (Co-Investigator)
01/01/24 → 31/12/28
Project: Research
-
PII: Printed Intelligence Infrastructure
Toivakka, M. (Principal Investigator), Xu, C. (Co-Principal Investigator), Bobacka, J. (Co-Principal Investigator), Viitala, T. (Co-Principal Investigator), Rosenholm, J. (Co-Principal Investigator), Österbacka, R. (Co-Principal Investigator), Anttu, N. (Co-Principal Investigator), Huynh, T. P. (Co-Principal Investigator), Peltonen, J. (Co-Principal Investigator), Wang, X. (Co-Principal Investigator), Zhang, H. (Co-Principal Investigator) & Wilen, C.-E. (Co-Principal Investigator)
01/01/24 → 31/12/28
Project: Research Council of Finland/Other Research Councils
-
3D Printing for Personalized Medicine and Customized Drug Delivery
Viitala, T. (Principal Investigator), Rosenholm, J. (Co-Principal Investigator) & Xu, C. (Co-Principal Investigator)
01/05/23 → 30/04/25
Project: Industry/Business Finland
-
Nordic POP (Patient-Oriented Products)
Rosenholm, J. (Principal Investigator), Zhang, H. (Co-Principal Investigator), Viitala, T. (Co-Investigator), Filppula, A. (Co-Investigator), Salo-Ahen, O. (Co-Principal Investigator), Bobacka, J. (Co-Principal Investigator), Salminen, T. A. (Co-Investigator), Johnson, M. (Co-Principal Investigator), Peltonen, J. (Co-Principal Investigator) & Wang, X. (Co-Investigator)
01/01/18 → 31/12/25
Project: Ministry / Government Agency
-
Exploiting the Warburg Effect: Co‐Delivery of Metformin and FOXK2 siRNA for Ovarian Cancer Therapy
Zhou, W., Ma, X., Xiao, J., He, X., Liu, C., Xu, X., Viitala, T., Feng, J. & Zhang, H., Mar 2024, In: Small Science. 4, 3Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile3 Citations (Scopus)1 Downloads (Pure) -
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting
Clubb, J., Kudling, T., Girych, M., Haybout, L., Pakola, S., Hamdan, F., Cervera-Carrascon, V., Hemmes, A., Grönberg-Vähä-Koskela, S., Santos, J., Quixabeira, D., Basnet, S., Heiniö, C., Arias, V., Jirovec, E., Kaptan, S., Havunen, R., Sorsa, S., Erikat, A. & Schwartz, J. & 7 others, , 3 Feb 2023, In: Frontiers in Immunology. 14, 20 p., 1060540.Research output: Contribution to journal › Article › Scientific › peer-review
3 Citations (Scopus) -
In Vitro Characterization and Real-Time Label-Free Assessment of the Interaction of Chitosan-Coated Niosomes with Intestinal Cellular Monolayers
Scurti, E., Martins, J. P., Celia, C., Palumbo, P., Lombardi, F., Iannotta, D., Di Marzio, L., Santos, H. A. & Viitala, T., 13 Jun 2023, In: Langmuir. 39, 23, p. 8255-8266 12 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile2 Citations (Scopus)24 Downloads (Pure) -
Monitoring silica core@shell nanoparticle-bacterial film interactions using the multi-parametric surface plasmon resonance technique
Mustafa, R. A., Parkkila, P., Rosenholm, J. M., Zhang, H. & Viitala, T., Aug 2023, In: Smart Medicine. 2, 3, 16 p., e20230012.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile39 Downloads (Pure) -
Assembly of Bleomycin Saccharide-Decorated Spherical Nucleic Acids
Tähtinen, V., Gulumkar, V., Maity, S. K., Yliperttula, A. M., Siekkinen, S., Laine, T., Lisitsyna, E., Haapalehto, I., Viitala, T., Vuorimaa-Laukkanen, E., Yliperttula, M. & Virta, P., 19 Jan 2022, In: Bioconjugate Chemistry. 33, 1, p. 206-218 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile7 Citations (Scopus)39 Downloads (Pure)
Activities
- 2 Hosting an academic visitor
-
Maxim Bril’kov
Viitala, T. (Host)
17 Apr 2023 → 17 May 2023Activity: Hosting a visitor › Hosting an academic visitor
-
Aryane Vigato
Rosenholm, J. (Host) & Viitala, T. (Host)
1 Sept 2022 → 31 Mar 2023Activity: Hosting a visitor › Hosting an academic visitor